Personalis, Inc. Investment Income, Interest
Personalis, Inc. (PSNL) reported Investment Income, Interest of $1.97 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-04
- Personalis, Inc. investment income, interest for the quarter ending 2026-06-30 was $1.97M, a 4.69% increase year-over-year.
- Personalis, Inc. investment income, interest for the quarter ending 2026-03-31 was $2.17M, a 7.15% increase year-over-year.
- Personalis, Inc. investment income, interest for the quarter ending 2025-12-31 was $1.57M, a 3.74% decline year-over-year.
- Personalis, Inc. investment income, interest for the quarter ending 2025-09-30 was $1.68M, a 21.39% increase year-over-year.
- Personalis, Inc. investment income, interest for fiscal 2025 was $7.16M, a 29.85% increase from fiscal 2024.
- Personalis, Inc. investment income, interest for fiscal 2024 was $5.51M, a 6.63% decline from fiscal 2023.
- Personalis, Inc. investment income, interest for fiscal 2023 was $5.90M, a 146.29% increase from fiscal 2022.
- Personalis, Inc. investment income, interest for fiscal 2022 was $2.40M, a 552.86% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.97M 10-Q · filed 2026-08-04 | $4.14M 10-Q · filed 2026-08-04 | $5.71M derived: sum of 3 quarters · filed 2026-08-04 | $7.39M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $2.17M 10-Q · filed 2026-05-07 | $3.74M derived: sum of 2 quarters · filed 2026-05-07 | $5.42M derived: sum of 3 quarters · filed 2026-05-07 | $7.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.25M derived: sum of 2 quarters · filed 2026-02-26 | $5.13M derived: sum of 3 quarters · filed 2026-08-04 | $7.16M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.68M 10-Q · filed 2025-11-04 | $3.56M derived: sum of 2 quarters · filed 2026-08-04 | $5.58M 10-Q · filed 2025-11-04 | $7.22M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $1.88M 10-Q · filed 2026-08-04 | $3.90M 10-Q · filed 2026-08-04 | $5.54M derived: sum of 3 quarters · filed 2026-08-04 | $6.92M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.03M 10-Q · filed 2026-05-07 | $3.66M derived: sum of 2 quarters · filed 2026-05-07 | $5.04M derived: sum of 3 quarters · filed 2026-05-07 | $6.18M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.02M derived: sum of 2 quarters · filed 2026-02-26 | $4.15M derived: sum of 3 quarters · filed 2026-02-26 | $5.51M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.38M 10-Q · filed 2025-11-04 | $2.52M derived: sum of 2 quarters · filed 2025-11-04 | $3.88M 10-Q · filed 2025-11-04 | $5.36M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $1.14M 10-Q · filed 2025-08-05 | $2.50M 10-Q · filed 2025-08-05 | $3.97M derived: sum of 3 quarters · filed 2025-08-05 | $5.68M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $1.36M 10-Q · filed 2025-05-06 | $2.84M derived: sum of 2 quarters · filed 2025-05-06 | $4.54M derived: sum of 3 quarters · filed 2025-05-06 | $6.01M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.18M derived: sum of 2 quarters · filed 2025-02-27 | $4.65M derived: sum of 3 quarters · filed 2025-02-27 | $5.90M 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.71M 10-Q · filed 2024-11-06 | $3.17M derived: sum of 2 quarters · filed 2024-11-06 | $4.42M 10-Q · filed 2024-11-06 | $5.58M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $1.47M 10-Q · filed 2024-08-07 | $2.72M 10-Q · filed 2024-08-07 | $3.88M derived: sum of 3 quarters · filed 2024-08-07 | $4.62M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $1.25M 10-Q · filed 2024-05-08 | $2.41M derived: sum of 2 quarters · filed 2024-05-08 | $3.16M derived: sum of 3 quarters · filed 2024-05-08 | $3.50M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.90M derived: sum of 2 quarters · filed 2024-02-28 | $2.25M derived: sum of 3 quarters · filed 2024-02-28 | $2.40M 10-K · filed 2024-02-28 |
| 2022-09-30 | $743.00K 10-Q · filed 2023-11-07 | $1.09M derived: sum of 2 quarters · filed 2023-11-07 | $1.24M 10-Q · filed 2023-11-07 | $1.32M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $349.00K 10-Q · filed 2023-08-08 | $493.00K 10-Q · filed 2023-08-08 | $574.00K derived: sum of 3 quarters · filed 2024-02-28 | $662.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $144.00K 10-Q · filed 2023-05-03 | $225.00K derived: sum of 2 quarters · filed 2024-02-28 | $313.00K derived: sum of 3 quarters · filed 2024-02-28 | $416.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $169.00K derived: sum of 2 quarters · filed 2024-02-28 | $272.00K derived: sum of 3 quarters · filed 2024-02-28 | $367.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $88.00K 10-Q · filed 2022-11-02 | $191.00K derived: sum of 2 quarters · filed 2022-11-02 | $286.00K 10-Q · filed 2022-11-02 | $362.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $103.00K 10-Q · filed 2022-08-03 | $198.00K 10-Q · filed 2022-08-03 | $274.00K derived: sum of 3 quarters · filed 2023-02-23 | $391.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $95.00K 10-Q · filed 2022-05-04 | $171.00K derived: sum of 2 quarters · filed 2023-02-23 | $288.00K derived: sum of 3 quarters · filed 2023-02-23 | $534.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $193.00K derived: sum of 2 quarters · filed 2023-02-23 | $439.00K derived: sum of 3 quarters · filed 2023-02-23 | $949.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $117.00K 10-Q · filed 2021-11-04 | $363.00K derived: sum of 2 quarters · filed 2021-11-04 | $873.00K 10-Q · filed 2021-11-04 | $1.45M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $246.00K 10-Q · filed 2021-08-04 | $756.00K 10-Q · filed 2021-08-04 | $1.34M derived: sum of 3 quarters · filed 2022-02-24 | $2.09M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $510.00K 10-Q · filed 2021-05-05 | $1.09M derived: sum of 2 quarters · filed 2022-02-24 | $1.85M derived: sum of 3 quarters · filed 2022-02-24 | $2.05M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $580.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.34M derived: sum of 2 quarters · filed 2022-02-24 | $1.54M derived: sum of 3 quarters · filed 2022-02-24 | $1.62M 10-K · filed 2022-02-24 |
| 2019-09-30 | $756.00K 10-Q · filed 2020-11-05 | $956.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.04M 10-Q · filed 2020-11-05 | $1.12M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $200.00K 10-Q · filed 2020-08-06 | $284.00K 10-Q · filed 2020-08-06 | $362.00K derived: sum of 3 quarters · filed 2021-02-25 | $445.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $84.00K 10-Q · filed 2020-05-07 | $162.00K derived: sum of 2 quarters · filed 2021-02-25 | $245.00K derived: sum of 3 quarters · filed 2021-02-25 | $316.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $161.00K derived: sum of 2 quarters · filed 2021-02-25 | $232.00K derived: sum of 3 quarters · filed 2021-02-25 | $293.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $83.00K 10-Q · filed 2019-11-13 | $154.00K derived: sum of 2 quarters · filed 2019-11-13 | $215.00K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $71.00K 10-Q · filed 2019-08-13 | $132.00K 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | $100.00K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |